Conference program at a glance

Sunday, May 8th 2022 | Monday, May 9th 2022 | Tuesday, May 10th 2022

» Speaker details

» Download presentations (only for registered participants)

Sunday, May 8^th 2022

15:30 onwards	Registration start - Check-In
16:00-17:00	Welcome Coffee & Networking
17:00-17:15	Welcome & Opening of the Swiss HLG Jubilee Conference 2022 Gabrielle Gache \| President Swiss HLG
17:15-18:00	Keynote: 20 Years Swiss HLG – 20 Years Deal Making! Are we today still discussing the same burning topics? How did our industry evolve over this period? Thomas Tóth von Kiskér \| Chief Executive Officer, Tillotts Pharma AG
18:00-18:45	Keynote: The Antimicrobial innovation challenge, what we have to do NOW Martin Heidecker \| Chief Investment Officer, AMR Action Fund
18:45-19:00	Award Ceremony Chair- Sharon Finch \| IPLS Board Member
19:00-19:30	Ice breaker Chris Isler & Luis Vieira \| Swiss HLG Board Members
19:30 - 21:30	Kick-off Dinner
21:30 onwards	Networking with peers

Monday, May 9^th 2022

Morning Session

07:00	Voluntary pre-conference morning run (meet at reception)
08:30–09:00	Swiss HLG General Assembly – members by invitation
09:20-09:30	Welcome & Housekeeping Session 1 Intro - How Partnering has enabled the industry to realize the promise of breakthrough science Zaki Sellam \| Swiss HLG Board Member
09:30-10:00	From the millennium to 2030: the deals and drivers that have made the pharmaceutical industry what it is today, and what will shape its future Sarah Rickwood \| VP, EMEA Thought Leadership and Marketing, IQVIA
10:00-10:30	Learning from the memory of life to develop next generation antibody therapeutics Fabian Buller \| Chief Business Officer, Neurimmune
10:30-11:00	Refreshment break
11:00-11:30	Accelerating translational research through collaboration and partnerships Michael R Huebner \| Director Early Innovation Partnering, J&J Innovation
11:30-12:00	Two decades of success in cell therapies in oncology: Looking back at contribution of landmark deals and an outlook on future deal-making Markus Werner \| Executive Director BD&L Oncology, Novartis Oncology
12:00-12:30	Panel discussion: How Partnering has enabled the industry to realize the promise of breakthrough science Sarah Rickwood, Fabian Buller, Michael R Huebner and Markus Werner
12:30-14:00	Lunch & Networking

Monday, May 9^th 2022

Afternoon Session

14:00-14:20	Group photo
14:20-14:30	Session 2 Intro - How global market and strategic customer evolution has impacted deal-making Ragip Ziyal \| Swiss HLG Board Member
14:30-15:00	The rise of payers in the determination of value: Implications for manufacturers and the BD process Jean-François Ricci \| Chief Access Officer, Alira Health Alexandra Wollersheim \| Partner & Transaction Advisory, Alira Health
15:00-15:30	How China became one of the largest world economies and how is it influencing the pharma industry Ana Cerdeira \| Vice President / Head Global Commercial / Early Assets, Grünenthal
15:30-16:00	Refreshment break
16:00-16:30	Partnering across the healthcare ecosystem Lu Zheng \| Head of Value Based Partnerships and Patient Solutions, Takeda EUCAN
16:30-17:00	Panel discussion: How global market and strategic customer evolution has impacted deal-making Jean-François Ricci, Alexandra Wollersheim, Ana Cerdeira and Lu Zheng
17:00-17:10	Wrap up of the day Sarah Holland \| Swiss HLG Board Member
18:00 onwards	Swiss HLG 20^th Jubilee Celebrations, apero and dinner in a scenic location
22:15 onwards	Networking with peers at Hotel Suisse Majestic

Tuesday, May 10^th 2022

07:00	Voluntary pre-conference morning run (meet at reception)
08:50-09:00	Welcome & Housekeeping Session 3 Intro - Transformation of Business Development and Venture Financing into Strategic Capabilities Laurence de Schoulepnikoff \| Swiss HLG Board Member
09:00-09:20	Evolution of Business Development organisations as the function has gained strategic importance Vikas Kabra \| Global Head Transactions, Roche Partnering
09:20-09:40	Business Development & Licensing at BI: The journey over the last years Sammy Brutsche \| Global Head Transactions & Contract Management, Boehringer Ingelheim
09:40-10:00	Joint Q&A Vikas Kabra and Sammy Brutsche
10:00-10:30	Future-proofing your BD&L talent today to win in the future Ludger Schwinn \| Senior Client Partner, KornFerry Alessandro Buccella \| Senior Partner, KornFerry
10:30-11:00	Refreshment break & Networking
11:00-11:20	Funding sustainable biotech innovation Andreas Wallnoefer \| Partner and Investor, Jeito Capital
11:20-11:40	Evolving biopharma VC & BD landscape Vincent Ossipow \| Partner, Omega Funds
11:40-12:00	Joint Q&A Andreas Wallnoefer and Vincent Ossipow
12:00-12:15	Closing Remarks Jean-Marc Séquier, Vice President Swiss HLG
12:15 onwards	Farewell Lunch & Networking